Kennedy Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Kennedy Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,214	Closed	-$201K	–	672
2021 Q2	$201K	Sell	1,214 -116,862	-99%	-$19.5M	﹤0.01%	619
2021 Q1	$18.1M	Buy	118,076 +8,307	+8%	+$1.13M	0.36%	58
2020 Q4	$13.8M	Sell	109,769 -1,719	-2%	-$192K	0.31%	85
2020 Q3	$11.3M	Buy	+111,488	New	+$11.4M	0.32%	73
2016 Q1	–	Sell	-39,164	Closed	-$1.77M	–	781
2015 Q4	$1.77M	Sell	39,164 -12,081	-24%	-$508K	0.04%	593
2015 Q3	$1.99M	Sell	51,245 -6,412	-11%	-$257K	0.04%	569
2015 Q2	$2.1M	Buy	+57,657	New	+$1.82M	0.04%	583

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Kennedy Capital Management's PRAH Position: Q3 2021 in Review

Kennedy Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,214 shares — an estimated $201K sold.

Kennedy Capital Management first reported a position in PRAH in Q2 2015 and held it in 7 quarters. The position peaked at $18.1M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Kennedy Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Kennedy Capital Management sold 1,214 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $201K.
Kennedy Capital Management first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 7 quarters.
Kennedy Capital Management's PRA Health Sciences, Inc. position peaked at $18.1M in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Kennedy Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.